this is very good news, it opens up all of UK, and soon we will see commercial treatments, very soon, I guess
....A major UK insurance company will now cover the cost of the OncoSil treatment for pancreatic cancer at the Imperial College Healthcare NHS Trust in London. This is big news because it means patients can get access to this advanced treatment without worrying about the price tag. Imperial College Healthcare NHS Trust is a leading hospital group in England, working closely with Imperial College London on medical research.
OncoSil's team worked together with Imperial College to make sure this insurance coverage was approved.
This step opens doors to potentially get more insurance companies on board, aiming to make this treatment accessible to more patients, not just in one hospital but across the UK.....
OSL Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)